Chris Press
Impact in
-
- Growth Hormone and Insulin-like Growth Factors
- Pituitary Gland Disorders and Treatments
- Thyroid Disorders and Treatments
- Pharmaceutical Science top 10%
Papers in
-
- Growth Hormone and Insulin-like Growth Factors 3
- Pituitary Gland Disorders and Treatments 2
- Diabetes Management and Research 1
-
- Inhalation and Respiratory Drug Delivery 3
- Co-authors
- Raymond L. Hintz (2 shared papers)Joseph M. Gertner (2 shared papers)William V. Tamborlane (2 shared papers)Stephanie A. Amiel (1 shared paper)Robert S. Sherwin (1 shared paper)Myron Genel (1 shared paper)Ron G. Rosenfeld (1 shared paper)Andrew G. Gianoukakis (1 shared paper)
- Journals
- European Journal of Pharmaceutics and Biopharmaceutics (1 paper)Pediatric Clinics of North America (1 paper)Diabetes (1 paper)International Journal of Pharmaceutics (1 paper)Vaccine (1 paper)
- Partner nations
- United StatesCanada
In The Last Decade
Chris Press
7 papers receiving 388 citations
Peers
Comparison fields: 5 of 63
- Endocrinology, Diabetes and Metabolism 248
- Pharmaceutical Science 35
- Ophthalmology 40
- Pathology and Forensic Medicine 79
- Endocrine and Autonomic Systems 20
Countries citing papers authored by Chris Press
This map shows the geographic impact of Chris Press's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris Press with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris Press more than expected).
Fields of papers citing papers by Chris Press
This network shows the impact of papers produced by Chris Press. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris Press. The network helps show where Chris Press may publish in the future.
Co-authors
The 25 scholars most cited alongside Chris Press, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1984 | 172 | |
| 2 | 2008 | 82 | |
| 3 | 1986 | 60 | |
| 4 | 2020 | 40 | |
| 5 | 2021 | 21 | |
| 6 | 2021 | 17 | |
| 7 | 1984 | 8 |
About Chris Press
Chris Press is a scholar working on Endocrinology, Diabetes and Metabolism, Pulmonary and Respiratory Medicine, Pharmaceutical Science, Food Science and Molecular Biology, having authored 7 papers that have together received 400 indexed citations. Recurring topics across this work include Drug Solubulity and Delivery Systems (3 papers), Inhalation and Respiratory Drug Delivery (3 papers), Microencapsulation and Drying Processes (3 papers), Growth Hormone and Insulin-like Growth Factors (3 papers), Pituitary Gland Disorders and Treatments (2 papers), Ophthalmology and Eye Disorders (1 paper), Diabetes Management and Research (1 paper) and Metabolism, Diabetes, and Cancer (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (248 citations), Pharmaceutical Science (35 citations), Ophthalmology (40 citations), Pathology and Forensic Medicine (79 citations) and Endocrine and Autonomic Systems (20 citations). Chris Press has collaborated with scholars based in United States and Canada. Frequent co-authors include Raymond L. Hintz, Joseph M. Gertner, William V. Tamborlane, Stephanie A. Amiel, Robert S. Sherwin, Myron Genel, Ron G. Rosenfeld, Andrew G. Gianoukakis, Richard P. Phipps and Alana Gerhardt. Their work appears in journals such as European Journal of Pharmaceutics and Biopharmaceutics, Pediatric Clinics of North America, Diabetes, International Journal of Pharmaceutics and Vaccine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.